Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030552 (paresis)
 5,831 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The dynamic state of hematoencephalic barrier (HEB) was estimated in Russian tick-borne encephalitic (RTBE) and in meningeal syndrome (Lyme's disease, LD). The enzyme immunoassays of neurospecific proteins in blood serum such as alpha 1-BG and enolase (NSE) were performed in the course of disease. The break of HEB at blood-brain direction was proved in patients with RTBE and LD for the proteins mentioned above. The blood serum NSE levels as well as their dynamics confirmed the functional alteration of brain neurons' permeability in LD and pronounced destruction of such neurons in RTBE. The acute increase of blood NSE concentration was observed within some days before the development of clinical signs of paresis. The authors suppose that the enzyme immunoassays of neurospecific proteins which are of rather high value for HEB permeability and neuronal destruction control may be successfully applied in monitoring of both therapy's efficacy and individualization of pharmacotherapy.
 ...
PMID:[Resistance of the hemato-encephalic barrier in tick-borne neural infection (Lyme disease and tick-borne encephalitis)]. 878 74

Ten dogs with neuroendocrine carcinoma of the liver were selected for inclusion in the study. Clinical signs were anorexia (7), vomiting (5), polydipsia/polyuria (3), icterus (2), lethargy (2), weight loss (2), paresis (1), ataxia (1), weakness (1), collapse (1), and urinary tract infection (1). Hematologic and biochemical abnormalities included anemia (2/8), leukocytosis (4/8), high liver enzyme activity (serum alkaline phosphatase, 7/9; alanine transaminase, 7/9; aspartate transaminase, 8/9), and high total bilirubin (6/9). Grossly, the tumors were diffuse, involving all liver lobes in six dogs, and two dogs had various-sized nodules in addition to diffuse involvement. Histologically, there were eight tumors with solid or trabecular pattern (group A), one tumor with cords or rows of neoplastic cells (group B), and one tumor with multiple rosette-like structures (group C). Immunohistochemical studies revealed that all 10 neoplasms were positive for at least one of the endocrine markers used: neuron-specific enolase (NSE; 8/10), synaptophysin (5/10), and chromogranin-A (3/10). A panel of NSE, chromagranin-A, and synaptophysin detected 100% of the tumors in our series. Electron microscopy confirmed the diagnosis by the presence of intracytoplasmic neurosecretory granules in the two examined cases. Our results show that neuroendocrine markers commonly used in humans can be used for the diagnosis of hepatic neuroendocrine carcinoma in dogs, preferably a panel of synaptophysin, chromagranin-A, and NSE because chromogranin-A alone is not as useful in dogs as in humans.
 ...
PMID:Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study. 1575 67